Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04001426 · ClinicalTrials.gov registry record · NA

Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device

A NA study, sponsored by FemPulse Corporation.

Completed
Registry status
NA
Development phase
2
Enrollment target

NCT04001426 is a NA study that has completed, run by FemPulse Corporation. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04001426, a NA study, has completed, sponsored by FemPulse Corporation.

COMPLETED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

The purpose of this feasibility clinical investigation is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.

Interventions

  • DEVICE The FemPulse System

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2019-04-04
Est. Completion 2019-12-31
Phase NA

Sponsor

FemPulse Corporation

6 total trials

What the Registry Record Tells You About NCT04001426

The ClinicalTrials.gov registry entry for NCT04001426 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is FemPulse Corporation, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which The FemPulse System is the first listed.

NCT04001426 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04001426 about?

NCT04001426 is a clinical study titled "Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device". The purpose of this feasibility clinical investigation is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.

What is the current status of trial NCT04001426?

This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2019-04-04. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT04001426?

The interventions under investigation include: The FemPulse System (DEVICE).

Who is sponsoring clinical trial NCT04001426?

This trial is sponsored by FemPulse Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.